Literature DB >> 3002686

Transferrin receptor bearing cells in the peripheral blood of patients with rheumatoid arthritis.

M Salmon, P A Bacon, D P Symmons, A D Blann.   

Abstract

Activated, proliferating lymphocytes are a feature of rheumatoid arthritis. They are present both in the synovial membrane and in the peripheral circulation. The expression of transferrin receptors(TFR) is a good marker of cellular proliferation. This study shows increased levels of circulating TFR-bearing lymphocytes in patients with rheumatoid arthritis (RA). The TFR+ population contains a disproportionately large number of T4+ cells, leading to a high T4:T8 ratio (5:1 in the TFR+ population, compared to 2:1 in the total circulating pool of lymphocytes). This reflects the pattern found in the rheumatoid synovium and suggests that lymphocyte activation in RA may be an extra-articular phenomenon. The TFR+ population also contains a range of non-T cells, including B cells, and a population bearing phenotypic similarities to natural killer (NK) cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002686      PMCID: PMC1577431     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Effect of iron transferrin on nucleic acid synthesis in phytohemagglutinin-stimulated human lymphocytes.

Authors:  J L Phillips; P Azari
Journal:  Cell Immunol       Date:  1975-01       Impact factor: 4.868

2.  Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage.

Authors:  H E Paulus; H I Machleder; S Levine; D T Yu; N S MacDonald
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug

3.  Transferrin receptors on human B and T lymphoblastoid cell lines.

Authors:  J W Larrick; P Cresswell
Journal:  Biochim Biophys Acta       Date:  1979-04-03

4.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  Transferrin binding by mitogen-activated human peripheral blood lymphocytes.

Authors:  G M Galbraith; J M Goust; S M Mercurio; R M Galbraith
Journal:  Clin Immunol Immunopathol       Date:  1980-08

6.  Transferrin receptor expression by stimulated cells in mixed lymphocyte culture.

Authors:  M Salmon; P A Bacon; D P Symmons; K W Walton
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

7.  Reactive lymphoid cells ('Immunoblasts') in autoimmune and haematological disorders.

Authors:  P A Bacon; R L Sewell; D Crowther
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

8.  Further characterization of the human inducer T cell subset defined by monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Transferrin and transferrin receptors in carcinoma of the breast.

Authors:  W P Faulk; B L Hsi; P J Stevens
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

10.  Response of the rheumatoid synovial membrane to exogenous immunization.

Authors:  J H Herman; J Bradley; M Ziff; J D Smiley
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

View more
  8 in total

1.  Activated, cytotoxic lymphocytes in systemic vasculitis.

Authors:  A D Blann; D G Scott
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  A cellular deficiency in the rheumatoid one-way mixed lymphocyte reaction.

Authors:  M Salmon; P A Bacon
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

3.  Abnormal populations of activated lymphocytes in the rheumatoid one-way MLR.

Authors:  M Salmon; P A Bacon
Journal:  Agents Actions       Date:  1986-12

4.  Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo.

Authors:  M D Smith; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

5.  Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis.

Authors:  C Plater-Zyberk; K A Rockett; R N Maini
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

6.  Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis.

Authors:  A Afeltra; M Galeazzi; G M Ferri; A Amoroso; O De Pità; F Porzio; L Bonomo
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

7.  Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications.

Authors:  G D Kitas; M Salmon; M Farr; J S Gaston; P A Bacon
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

8.  Lymphopenia in rheumatoid arthritis.

Authors:  D P Symmons; M Farr; M Salmon; P A Bacon
Journal:  J R Soc Med       Date:  1989-08       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.